The global Medications for Chronic Pain Treatment market was valued at million in 2024 and is projected to reach US$ million by 2031, at a CAGR of %during the forecast period.
Medications for chronic pain treatment are pharmaceutical drugs prescribed by healthcare professionals to manage persistent and long-lasting pain conditions. Chronic pain is often defined as pain that persists for three months or longer and can result from various underlying causes, including injury, illness, or medical conditions. The goal of chronic pain medication is to alleviate pain, improve the patient\"s quality of life, and enhance their ability to function.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medications for Chronic Pain Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Medications for Chronic Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medications for Chronic Pain Treatment. This report contains market size and forecasts of Medications for Chronic Pain Treatment in global, including the following market information:
Global Medications for Chronic Pain Treatment market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Medications for Chronic Pain Treatment companies in 2024 (%)
Total Market by Segment:
Global Medications for Chronic Pain Treatment market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Medications for Chronic Pain Treatment market segment percentages, by Type, 2024 (%)
Nonopioid
Opioids
Global Medications for Chronic Pain Treatment market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Medications for Chronic Pain Treatment market segment percentages, by Application, 2024 (%)
Hospital
Pharmacy
Other
Global Medications for Chronic Pain Treatment market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Medications for Chronic Pain Treatment market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medications for Chronic Pain Treatment revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Medications for Chronic Pain Treatment revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Abbott Laboratories
Novartis AG
Johnson and Johnson Services Inc.
YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
BAYER
Jiangsu Hengrui Medicine Co,.Ltd
REYOUNG
Southwest Pharmaceutical Co., Ltd.
Depomed
Endo International plc.
Purdue Pharma L.P.
AstraZeneca plc.
Merck & Co.
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medications for Chronic Pain Treatment, market overview.
Chapter 2: Global Medications for Chronic Pain Treatment market size in revenue.
Chapter 3: Detailed analysis of Medications for Chronic Pain Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medications for Chronic Pain Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Medications for Chronic Pain Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Medications for Chronic Pain Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medications for Chronic Pain Treatment Overall Market Size
2.1 Global Medications for Chronic Pain Treatment Market Size: 2024 VS 2031
2.2 Global Medications for Chronic Pain Treatment Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Medications for Chronic Pain Treatment Players in Global Market
3.2 Top Global Medications for Chronic Pain Treatment Companies Ranked by Revenue
3.3 Global Medications for Chronic Pain Treatment Revenue by Companies
3.4 Top 3 and Top 5 Medications for Chronic Pain Treatment Companies in Global Market, by Revenue in 2024
3.5 Global Companies Medications for Chronic Pain Treatment Product Type
3.6 Tier 1, Tier 2, and Tier 3 Medications for Chronic Pain Treatment Players in Global Market
3.6.1 List of Global Tier 1 Medications for Chronic Pain Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Medications for Chronic Pain Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Medications for Chronic Pain Treatment Market Size Markets, 2024 & 2031
4.1.2 Nonopioid
4.1.3 Opioids
4.2 Segmentation by Type - Global Medications for Chronic Pain Treatment Revenue & Forecasts
4.2.1 Segmentation by Type - Global Medications for Chronic Pain Treatment Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Medications for Chronic Pain Treatment Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Medications for Chronic Pain Treatment Market Size, 2024 & 2031
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 Segmentation by Application - Global Medications for Chronic Pain Treatment Revenue & Forecasts
5.2.1 Segmentation by Application - Global Medications for Chronic Pain Treatment Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Medications for Chronic Pain Treatment Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Medications for Chronic Pain Treatment Market Size, 2024 & 2031
6.2 By Region - Global Medications for Chronic Pain Treatment Revenue & Forecasts
6.2.1 By Region - Global Medications for Chronic Pain Treatment Revenue, 2020-2025
6.2.2 By Region - Global Medications for Chronic Pain Treatment Revenue, 2026-2031
6.2.3 By Region - Global Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Medications for Chronic Pain Treatment Revenue, 2020-2031
6.3.2 United States Medications for Chronic Pain Treatment Market Size, 2020-2031
6.3.3 Canada Medications for Chronic Pain Treatment Market Size, 2020-2031
6.3.4 Mexico Medications for Chronic Pain Treatment Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Medications for Chronic Pain Treatment Revenue, 2020-2031
6.4.2 Germany Medications for Chronic Pain Treatment Market Size, 2020-2031
6.4.3 France Medications for Chronic Pain Treatment Market Size, 2020-2031
6.4.4 U.K. Medications for Chronic Pain Treatment Market Size, 2020-2031
6.4.5 Italy Medications for Chronic Pain Treatment Market Size, 2020-2031
6.4.6 Russia Medications for Chronic Pain Treatment Market Size, 2020-2031
6.4.7 Nordic Countries Medications for Chronic Pain Treatment Market Size, 2020-2031
6.4.8 Benelux Medications for Chronic Pain Treatment Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Medications for Chronic Pain Treatment Revenue, 2020-2031
6.5.2 China Medications for Chronic Pain Treatment Market Size, 2020-2031
6.5.3 Japan Medications for Chronic Pain Treatment Market Size, 2020-2031
6.5.4 South Korea Medications for Chronic Pain Treatment Market Size, 2020-2031
6.5.5 Southeast Asia Medications for Chronic Pain Treatment Market Size, 2020-2031
6.5.6 India Medications for Chronic Pain Treatment Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Medications for Chronic Pain Treatment Revenue, 2020-2031
6.6.2 Brazil Medications for Chronic Pain Treatment Market Size, 2020-2031
6.6.3 Argentina Medications for Chronic Pain Treatment Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Medications for Chronic Pain Treatment Revenue, 2020-2031
6.7.2 Turkey Medications for Chronic Pain Treatment Market Size, 2020-2031
6.7.3 Israel Medications for Chronic Pain Treatment Market Size, 2020-2031
6.7.4 Saudi Arabia Medications for Chronic Pain Treatment Market Size, 2020-2031
6.7.5 UAE Medications for Chronic Pain Treatment Market Size, 2020-2031
7 Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Medications for Chronic Pain Treatment Major Product Offerings
7.1.4 Pfizer Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.1.5 Pfizer Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Medications for Chronic Pain Treatment Major Product Offerings
7.2.4 Abbott Laboratories Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Corporate Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Medications for Chronic Pain Treatment Major Product Offerings
7.3.4 Novartis AG Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Johnson and Johnson Services Inc.
7.4.1 Johnson and Johnson Services Inc. Corporate Summary
7.4.2 Johnson and Johnson Services Inc. Business Overview
7.4.3 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Major Product Offerings
7.4.4 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.4.5 Johnson and Johnson Services Inc. Key News & Latest Developments
7.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
7.5.1 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Corporate Summary
7.5.2 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview
7.5.3 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Major Product Offerings
7.5.4 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.5.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Key News & Latest Developments
7.6 BAYER
7.6.1 BAYER Corporate Summary
7.6.2 BAYER Business Overview
7.6.3 BAYER Medications for Chronic Pain Treatment Major Product Offerings
7.6.4 BAYER Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.6.5 BAYER Key News & Latest Developments
7.7 Jiangsu Hengrui Medicine Co,.Ltd
7.7.1 Jiangsu Hengrui Medicine Co,.Ltd Corporate Summary
7.7.2 Jiangsu Hengrui Medicine Co,.Ltd Business Overview
7.7.3 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Major Product Offerings
7.7.4 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.7.5 Jiangsu Hengrui Medicine Co,.Ltd Key News & Latest Developments
7.8 REYOUNG
7.8.1 REYOUNG Corporate Summary
7.8.2 REYOUNG Business Overview
7.8.3 REYOUNG Medications for Chronic Pain Treatment Major Product Offerings
7.8.4 REYOUNG Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.8.5 REYOUNG Key News & Latest Developments
7.9 Southwest Pharmaceutical Co., Ltd.
7.9.1 Southwest Pharmaceutical Co., Ltd. Corporate Summary
7.9.2 Southwest Pharmaceutical Co., Ltd. Business Overview
7.9.3 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Major Product Offerings
7.9.4 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.9.5 Southwest Pharmaceutical Co., Ltd. Key News & Latest Developments
7.10 Depomed
7.10.1 Depomed Corporate Summary
7.10.2 Depomed Business Overview
7.10.3 Depomed Medications for Chronic Pain Treatment Major Product Offerings
7.10.4 Depomed Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.10.5 Depomed Key News & Latest Developments
7.11 Endo International plc.
7.11.1 Endo International plc. Corporate Summary
7.11.2 Endo International plc. Business Overview
7.11.3 Endo International plc. Medications for Chronic Pain Treatment Major Product Offerings
7.11.4 Endo International plc. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.11.5 Endo International plc. Key News & Latest Developments
7.12 Purdue Pharma L.P.
7.12.1 Purdue Pharma L.P. Corporate Summary
7.12.2 Purdue Pharma L.P. Business Overview
7.12.3 Purdue Pharma L.P. Medications for Chronic Pain Treatment Major Product Offerings
7.12.4 Purdue Pharma L.P. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.12.5 Purdue Pharma L.P. Key News & Latest Developments
7.13 AstraZeneca plc.
7.13.1 AstraZeneca plc. Corporate Summary
7.13.2 AstraZeneca plc. Business Overview
7.13.3 AstraZeneca plc. Medications for Chronic Pain Treatment Major Product Offerings
7.13.4 AstraZeneca plc. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.13.5 AstraZeneca plc. Key News & Latest Developments
7.14 Merck & Co.
7.14.1 Merck & Co. Corporate Summary
7.14.2 Merck & Co. Business Overview
7.14.3 Merck & Co. Medications for Chronic Pain Treatment Major Product Offerings
7.14.4 Merck & Co. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.14.5 Merck & Co. Key News & Latest Developments
7.15 GlaxoSmithKline plc.
7.15.1 GlaxoSmithKline plc. Corporate Summary
7.15.2 GlaxoSmithKline plc. Business Overview
7.15.3 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Major Product Offerings
7.15.4 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.15.5 GlaxoSmithKline plc. Key News & Latest Developments
7.16 Teva Pharmaceutical Industries Ltd.
7.16.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.16.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.16.3 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Major Product Offerings
7.16.4 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Revenue in Global Market (2020-2025)
7.16.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Medications for Chronic Pain Treatment Market Opportunities & Trends in Global Market
Table 2. Medications for Chronic Pain Treatment Market Drivers in Global Market
Table 3. Medications for Chronic Pain Treatment Market Restraints in Global Market
Table 4. Key Players of Medications for Chronic Pain Treatment in Global Market
Table 5. Top Medications for Chronic Pain Treatment Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Medications for Chronic Pain Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Medications for Chronic Pain Treatment Revenue Share by Companies, 2020-2025
Table 8. Global Companies Medications for Chronic Pain Treatment Product Type
Table 9. List of Global Tier 1 Medications for Chronic Pain Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medications for Chronic Pain Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Medications for Chronic Pain Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Medications for Chronic Pain Treatment Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2026-2031
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Medications for Chronic Pain Treatment Product Offerings
Table 32. Pfizer Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 33. Pfizer Key News & Latest Developments
Table 34. Abbott Laboratories Corporate Summary
Table 35. Abbott Laboratories Medications for Chronic Pain Treatment Product Offerings
Table 36. Abbott Laboratories Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. Novartis AG Corporate Summary
Table 39. Novartis AG Medications for Chronic Pain Treatment Product Offerings
Table 40. Novartis AG Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 41. Novartis AG Key News & Latest Developments
Table 42. Johnson and Johnson Services Inc. Corporate Summary
Table 43. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Product Offerings
Table 44. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 45. Johnson and Johnson Services Inc. Key News & Latest Developments
Table 46. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Corporate Summary
Table 47. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Product Offerings
Table 48. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 49. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Key News & Latest Developments
Table 50. BAYER Corporate Summary
Table 51. BAYER Medications for Chronic Pain Treatment Product Offerings
Table 52. BAYER Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 53. BAYER Key News & Latest Developments
Table 54. Jiangsu Hengrui Medicine Co,.Ltd Corporate Summary
Table 55. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Product Offerings
Table 56. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 57. Jiangsu Hengrui Medicine Co,.Ltd Key News & Latest Developments
Table 58. REYOUNG Corporate Summary
Table 59. REYOUNG Medications for Chronic Pain Treatment Product Offerings
Table 60. REYOUNG Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 61. REYOUNG Key News & Latest Developments
Table 62. Southwest Pharmaceutical Co., Ltd. Corporate Summary
Table 63. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Product Offerings
Table 64. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 65. Southwest Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 66. Depomed Corporate Summary
Table 67. Depomed Medications for Chronic Pain Treatment Product Offerings
Table 68. Depomed Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 69. Depomed Key News & Latest Developments
Table 70. Endo International plc. Corporate Summary
Table 71. Endo International plc. Medications for Chronic Pain Treatment Product Offerings
Table 72. Endo International plc. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 73. Endo International plc. Key News & Latest Developments
Table 74. Purdue Pharma L.P. Corporate Summary
Table 75. Purdue Pharma L.P. Medications for Chronic Pain Treatment Product Offerings
Table 76. Purdue Pharma L.P. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 77. Purdue Pharma L.P. Key News & Latest Developments
Table 78. AstraZeneca plc. Corporate Summary
Table 79. AstraZeneca plc. Medications for Chronic Pain Treatment Product Offerings
Table 80. AstraZeneca plc. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 81. AstraZeneca plc. Key News & Latest Developments
Table 82. Merck & Co. Corporate Summary
Table 83. Merck & Co. Medications for Chronic Pain Treatment Product Offerings
Table 84. Merck & Co. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 85. Merck & Co. Key News & Latest Developments
Table 86. GlaxoSmithKline plc. Corporate Summary
Table 87. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Product Offerings
Table 88. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 89. GlaxoSmithKline plc. Key News & Latest Developments
Table 90. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 91. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Product Offerings
Table 92. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Revenue (US$, Mn) & (2020-2025)
Table 93. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
List of Figures
Figure 1. Medications for Chronic Pain Treatment Product Picture
Figure 2. Medications for Chronic Pain Treatment Segment by Type in 2024
Figure 3. Medications for Chronic Pain Treatment Segment by Application in 2024
Figure 4. Global Medications for Chronic Pain Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Medications for Chronic Pain Treatment Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Medications for Chronic Pain Treatment Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Medications for Chronic Pain Treatment Revenue in 2024
Figure 9. Segmentation by Type – Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
Figure 13. By Region - Global Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
Figure 14. By Country - North America Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
Figure 15. United States Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
Figure 19. Germany Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 20. France Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
Figure 27. China Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 31. India Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
Figure 33. Brazil Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Medications for Chronic Pain Treatment Revenue Market Share, 2020-2031
Figure 36. Turkey Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Medications for Chronic Pain Treatment Revenue, (US$, Mn), 2020-2031
Figure 40. Pfizer Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Abbott Laboratories Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Novartis AG Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. BAYER Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. REYOUNG Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Depomed Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Endo International plc. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Purdue Pharma L.P. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. AstraZeneca plc. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Merck & Co. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
